Dj Cero Therapeutics Files 8K - Entry Into Definitive Agreement >Cero

Shares of Grab Holdings Limited rose sharply in today's pre-market trading after the company posted better-than-expected results for its third quarter and raised its 2024 outlook.

The company reported quarterly earnings of 1 cent per share, compared to consensus estimates of a loss of 1 cent per share.

Grab shares surged 12.3% to $4.92 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

• XBP Europe Holdings, Inc. gained 79.3% to $1.63 in pre-market trading after Reaktr announced the availability of SecAi on Oracle Cloud Infrastructure and in the Oracle Cloud Marketplace.
• BTC Digital Ltd. rose 48% to $3.73 in pre-market trading after gaining around 36% on Monday.
• MSP Recovery, Inc. gained 45.6% to $0.1845 in pre-market trading. LifeWallet announced $5.9 million in comprehensive settlements, beta tests new clearinghouse solution to tackle medicare waste.
• LogicMark, Inc. shares rose 31.7% to $0.1752 in pre-market trading after gaining 8% on Monday.
• Bridger Aerospace Group Holdings, Inc. gained 28.6% to $4.50 in pre-market trading after the company reported better-than-expected third-quarter revenue results and raised its FY24 revenue guidance.
• MultiMetaVerse Holdings Limited climbed 24.4% to $0.5200 in pre-market trading. MultiMetaVerse recently provided updates on its joint venture with Zhenghe.
• Taoping Inc. gained 13.7% to $0.4561 in pre-market trading.
• Luminar Technologies, Inc. rose 13.7% to $1.16 in pre-market trading after the company provided a business update for the third quarter after the bell on Monday. Luminar said it continues to meet all key deliverables for the Volvo EX90 production ramp. The lidar company said it shipped more product in the third quarter than it did in the past three quarters combined.
• Taysha Gene Therapies, Inc. gained 11.6% to $1.82 in pre-market trading. Taysha Gene Therapies will report its financial results for the third quarter ended Sept. 30, on Wednesday, Nov. 13.

Losers

• Neurogene Inc. shares tumbled 32.9% to $47.99 in pre-market trading after the company reported interim efficacy data from first four low-dose pediatric participants in NGN-401 gene therapy clinical trial for Rett syndrome
• 1847 Holdings LLC shares fell 30.7% to $1.38 in pre-market trading after jumping 727% on Monday.
• Destiny Tech100 Inc. declined 21.3% to $33.40 in pre-market trading after gaining 17% on Monday.
• Signing Day Sports, Inc. shares fell 19.8% to $0.2000 in pre-market trading after gaining 35% on Monday.
• Agora, Inc. fell 13.8% to $4.32 in pre-market trading. Agora will release its financial results for the third quarter ended Sept. 30 after the closing bell on Nov. 25.
• CERo Therapeutics Holdings, Inc. dipped 13.3% to $0.17 in pre-market trading. CERo Therapeutics shares jumped 180% on Monday after the company announced the presentation of preclinical data demonstrating the capability of CER-1236 to kill ovarian cancer cells in preclinical models
• Matinas BioPharma Holdings, Inc. fell 12.7% to $0.7850 in pre-market trading after surging over 29% on Monday.
• Oragenics, Inc. fell 10.7% to $0.3320 in today's pre-market trading.
• Bionomics Limited shares dipped 10.5% to $0.32 in pre-market trading after falling 9% on Monday.
• Zeta Global Holdings Corp. fell 9.8% to $33.15 in pre-market trading following third-quarter results.

Now Read This:

• Jim Cramer: This Tech Stock Can ‘Go To 160,’ Recommends Buying Domino’s Pizza

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Health care stocks fell late Monday afternoon with the NYSE Health Care Index down 0.4% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.7%.

The iShares Biotechnology ETF (IBB) declined 0.6%.

In corporate news, Evotec shares surged 18% after Bloomberg reported the company is the subject of a potential takeover bid by Triton Partners.

RAPT Therapeutics shares plunged 39% after the company said Monday it's ending its zelnecirnon program after the US Food and Drug Administration put a hold on two trials assessing the drug as a potential treatment for asthma and atopic dermatitis.

CERo Therapeutics shares soared 165%. The company said Monday that it presented preclinical data demonstrating the capability of its lead compound CER-1236 to kill ovarian cancer cells in preclinical models with no indications of toxicity in animal models.

AbbVie shares tumbled 12%. The company said its two phase 2 trials assessing emraclidine in adult patients with schizophrenia and acute exacerbation of psychotic symptoms failed to meet their primary goal.

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling more than 50 points on Monday.

The Dow traded up 0.76% to 44,324.99 while the NASDAQ fell 0.15% to 19,257.81. The S&P 500 also rose, gaining, 0.04% to 5,998.191.

Check This Out: Top 4 Health Care Stocks That May Plunge This Quarter

Leading and Lagging Sectors

Financials shares surged by 1.4% on Monday.

In trading on Monday, information technology shares fell by 1.3%.

Top Headline

Aramark reported better-than-expected fourth-quarter financial results and announced a $500 million share repurchase program. Also, the company approved a 11% increase to its quarterly dividend.

Revenue grew 5% year-over-year (Organic revenue: +7%) to $4.42 billion, missing the consensus of $4.46 billion. Adjusted EPS of 54 cents exceeded the consensus of 53 cents.

Aramark's Board of Directors approved an 11% increase in the quarterly dividend, raising it to 10.5 cents per share. The dividend will be payable on December 12, 2024, to stockholders of record as of December 2, 2024

Equities Trading UP

• CERo Therapeutics Holdings, Inc. shares shot up 122% to $0.1552 after the company announced the presentation of preclinical data demonstrating the capability of CER-1236 to kill ovarian cancer cells in preclinical models
• Shares of Canaan Inc. got a boost, surging 34% to $1.6915 after Bitcoin rose above $82,000.
• MARA Holdings, Inc. shares were also up, gaining 25% to $23.96 amid strength in Bitcoin.

Equities Trading DOWN

• 1847 Holdings LLC shares dropped 40% to $2.1600. 1847 Holdings signed a definitive agreement to acquire a cabinet, door & millwork manufacturer for $18.75 million.
• Shares of RAPT Therapeutics, Inc. were down 44% to $1.6250 after the company terminated its Zelnecirnon program following an FDA clinical hold due to a severe adverse event involving liver injury.
• Sapiens International Corporation N.V. was down, falling 26% to $29.25 after the company reported worse-than-expected third-quarter EPS and sales and lowered its FY24 revenue guidance.

Commodities

In commodity news, oil traded down 3.1% to $68.18 while gold traded down 2.8% at $2,619.40.

Silver traded down 2.6% to $30.620 on Monday, while copper fell 1.8% to $4.2270.

Euro zone

European shares closed higher today. The eurozone's STOXX 600 gained 1.13%, Germany's DAX gained 1.21% and France's CAC 40 gained 1.20%. Spain's IBEX 35 Index rose 0.40%, while London's FTSE 100 rose 0.65%.

The BNP Paribas Real Estate Construction PMI in Ireland rose to 49.4 in October versus 49.0 in September,

Asia Pacific Markets

Asian markets closed mostly higher on Monday, with Japan's Nikkei 225 gaining 0.08%, Hong Kong's Hang Seng Index falling 1.45%, China's Shanghai Composite Index gaining 0.51% and India's BSE Sensex gaining 0.01%.

China's annual inflation rate was 0.3% in October compared to September's reading of 0.4%, while producer prices declined by 2.9% year-over-year in October. China’s vehicle sales climbed by 7% year-over-year to 3.05 million units in October compared to a 1.7% decline in the prior month.

The gauge for Japan's service sector fell to 47.5 in October compared to a revised reading of 47.8 in the prior month, while Japan's current account surplus fell to JPY 1,717.1 billion in September from JPY 2,954.2 billion in the year-ago month.

Economics

No major economic reports are scheduled for released today.

Now Read This:

• Aramark, Live Nation Entertainment And 3 Stocks To Watch Heading Into Monday

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

CERo Therapeutics Holdings, Inc. shares are moving higher Monday after the company presented preclinical data for its lead compound.

The Details: CERo Therapeutics announced preclinical data showing the capability of lead compound CER-1236 to kill ovarian cancer cells in preclinical models with no indications of toxicity in animal models.

“We have long contended that CER-1236 has application in multiple cancer types. While we await the opportunity to introduce our compound into the clinic for AML, we continue to see other models in which there is utility and minimal-to-no toxicity,” said Chris Ehrlich, interim CEO of CERo Therapeutics.

“These data are of particular interest as the Company plans to apply for Orphan designation at the appropriate time in clinical development. Regardless, these data are further confirmation that our approach has enormous potential to go beyond some of the limitations of current chemotherapy approaches.”

CERo presented the data in a poster at the Society for Immunology of Cancer 2024 conference in Houston at the end of last week.

Investigators assessed CER-1236 on the immune receptor TIM-4-L in ovarian cancer cell lines and concluded that CER-1236 specificity to TIM-L-4 could provide an attractive option for treating ovarian cancer.

CERo shares are moving on abnormally high volume Monday. More than 1.2 billion shares have already been traded in the session, which is well above the stock’s average session volume of about 8.6 million, according to data from Benzinga Pro.

See Also: Lucid CEO Scrambles For Damage Control As Shares Plunge 47% This Year: ‘As A Major Shareholder...Believe Me, Nobody Is More Incentivized Than Me For Success’

CERO Price Action: At the time of writing, CERo Therapeutics shares were up 157.3% at 18 cents, according to data from Benzinga Pro.

Image: Unsplash/ Volodymyr Hryshchenko

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling more than 50 points on Monday.

The Dow traded up 0.69% to 44,294.18 while the NASDAQ fell 0.36% to 19,217.22. The S&P 500 also fell, dropping, 0.04% to 5,993.15.

Check This Out: Top 4 Health Care Stocks That May Plunge This Quarter

Leading and Lagging Sectors

Financials shares surged by 1.5% on Monday.

In trading on Monday, information technology shares fell by 1.4%.

Top Headline

Shares of Monday.com Ltd fell around 16% on Monday after the company reported results for its third quarter.

The company reported fiscal third-quarter 2024 revenue growth of 33% Y/Y to $251.0 million, beating the analyst consensus estimate of $246.1 million. The project management software company’s adjusted EPS of 85 cents beat the analyst consensus estimate of 63 cents.

Monday.com raised 2024 revenue guidance to $964 million–$966 million (prior $956 million–$961 million) against the consensus of $960.2 million and an adjusted operating margin of 12%–13% (prior 10%-11%)

Equities Trading UP

• CERo Therapeutics Holdings, Inc. shares shot up 155% to $0.1770 after the company announced the presentation of preclinical data demonstrating the capability of CER-1236 to kill ovarian cancer cells in preclinical models
• Shares of Canaan Inc. got a boost, surging 35% to $1.7013 after Bitcoin rose above $82,000.
• MARA Holdings, Inc. shares were also up, gaining 25% to $24.06 amid strength in Bitcoin.

Equities Trading DOWN

• 1847 Holdings LLC shares dropped 38% to $2.2550. 1847 Holdings signed a definitive agreement to acquire a cabinet, door & millwork manufacturer for $18.75 million.
• Shares of RAPT Therapeutics, Inc. were down 45% to $1.5994 after the company terminated its Zelnecirnon program following an FDA clinical hold due to a severe adverse event involving liver injury.
• Sapiens International Corporation N.V. was down, falling 26% to $29.13 after the company reported worse-than-expected third-quarter EPS and sales and lowered its FY24 revenue guidance.

Commodities

In commodity news, oil traded down 3.2% to $68.10 while gold traded down 2.7% at $2,621.70.

Silver traded down 2.8% to $30.570 on Monday, while copper fell 1.3% to $4.2495.

Euro zone

European shares were higher today. The eurozone's STOXX 600 gained 1.14%, Germany's DAX gained 1.28% and France's CAC 40 gained 1.16%. Spain's IBEX 35 Index rose 0.42%, while London's FTSE 100 rose 0.61%.

The BNP Paribas Real Estate Construction PMI in Ireland rose to 49.4 in October versus 49.0 in September,

Asia Pacific Markets

Asian markets closed mostly higher on Monday, with Japan's Nikkei 225 gaining 0.08%, Hong Kong's Hang Seng Index falling 1.45%, China's Shanghai Composite Index gaining 0.51% and India's BSE Sensex gaining 0.01%.

China's annual inflation rate was 0.3% in October compared to September's reading of 0.4%, while producer prices declined by 2.9% year-over-year in October. China’s vehicle sales climbed by 7% year-over-year to 3.05 million units in October compared to a 1.7% decline in the prior month.

The gauge for Japan's service sector fell to 47.5 in October compared to a revised reading of 47.8 in the prior month, while Japan's current account surplus fell to JPY 1,717.1 billion in September from JPY 2,954.2 billion in the year-ago month.

Economics

No major economic reports are scheduled for released today.

Now Read This:

• Aramark, Live Nation Entertainment And 3 Stocks To Watch Heading Into Monday

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.